[Federal Register Volume 89, Number 18 (Friday, January 26, 2024)]
[Notices]
[Pages 5246-5247]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01574]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Biological Chemistry and Macromolecular
Biophysics.
Date: February 21, 2024.
Time: 10:00 a.m. to 6:00 p.m.
[[Page 5247]]
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Vandana Kumari, Ph.D., Scientific Review
Officer, Center for Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 496-3290, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Collaborative R01--Clinical Studies of Mental Illness.
Date: February 21, 2024.
Time: 11:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW Washington, DC 20015.
Contact Person: Allison Kurti, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 1007J, Bethesda, MD 20892, (301) 594-1814,
[email protected].
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Cancer Prevention Study Section.
Date: February 22-23, 2024.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD
20852.
Contact Person: Byung Min Chung, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496-4056,
[email protected].
Name of Committee: Biology of Development and Aging Integrated
Review Group; Advancing Therapeutics A Study Section.
Date: February 22-23, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Watergate, 2650 Virginia Avenue NW, Washington, DC
20037,
Contact Person: Maureen Shuh, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 480-4097,
[email protected].
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group; Clinical Neuroimmunology and Brain Tumors
Study Section
Date: February 22-23, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aleksey G Kazantsev, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5201, Bethesda, MD 20817, 301-
435-1042, [email protected].
Name of Committee: Biological Chemistry and Macromolecular
Biophysics Integrated Review Group; Macromolecular Structure and
Function B Study Section.
Date: February 22-23, 2024.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency, Bethesda One, Bethesda Metro Center,
Bethesda, MD 20814.
Contact Person: Alexei A Yeliseev, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 443-0552,
[email protected].
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group; Adult Psychopathology and Disorders of
Aging Study Section.
Date: February 22-23, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Benjamin G Shapero, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182, MSC 7848, Bethesda, MD
20892, (301) 402-4786, [email protected].
Name of Committee: Vascular and Hematology Integrated Review
Group; Hemostasis, Thrombosis, Blood Cells and Transfusion Study
Section.
Date: February 22-23, 2024.
Time: 9:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Vivian Tang, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 594-6208
[email protected].
Name of Committee: Infectious Diseases and Immunology B
Integrated Review Group; Hypersensitivity, Autoimmune, and Immune-
mediated Diseases Study Section
Date: February 22-23, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Xinrui Li, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 594-2084,
[email protected].
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group; Molecular Genetics Study Section.
Date: February 22-23, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Altaf Ahmad Dar, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 827-2680,
[email protected].
Name of Committee: Risk, Prevention and Health Behavior
Integrated Review Group; Social Psychology, Personality and
Interpersonal Processes Study Section
Date: February 22-23, 2024.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shahrzad Mavandadi, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496-4792,
[email protected].
Name of Committee: Infectious Diseases and Immunology B
Integrated Review Group; Immunity and Host Defense Study Section.
Date: February 22-23, 2024.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alok Mulky, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4203, Bethesda, MD 20892, (301) 435-3566,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Collaborative Applications: Clinical Studies of Mental
Illness.
Date: February 22, 2024.
Time: 3:00 p.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications..
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Benjamin G Shapero, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182, MSC 7848, Bethesda, MD
20892, (301) 402-4786, [email protected].
Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 23, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-01574 Filed 1-25-24; 8:45 am]
BILLING CODE 4140-01-P